Nuvolone and Aguzzi (1) ascribed to the effect of a 129-Sirpa polymorphism, a macrophage phenotype we had previously attributed to PrP C , and we acknowledge that comparisons of wild-type and Prnp-null mice are subject to the flanking gene problem, as are many other studies of genetically modified mice. However, our current suggestion of a PrP C -monoaminergic link, consistent with the scaffold hypothesis, additionally relies on the binding of PrP C to monoaminergic markers.
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Indeed, inference that Beckman's data result from Sirpa polymorphisms is unlikely. Our Prnp-null mice differed from wild-type in forced swim (FST), tail suspension (TST), and novelty suppressed feeding tests, whereas a truncated SIRP␣ modulated FST, but not TST, probably due to FST properties not shared with TST and, also differing from our results (2), produced no change in dopamine levels (3). Moreover, the inconsistent relative performances of B6 and 129 mice in depression-related tests reviewed by Jacobson and Cryan (4) 
